康为世纪 (688426)
Jiangsu Cowin Biotech Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 11249.37
- Circulating A-Shares(W): 3799.33
- Earnings Per Share(RMB): -0.6900
- Net Assets Per Share(RMB): 12.3609
- Operating Revenue(W RMB): 13957.42
- Total Profit(W RMB): -8188.00
- **Net Profit Attributable to Parent(W RMB) **: -7616.26
- Net Profit Growth Rate(%): 20.37
- Weighted Return on Equity(%): -5.3500
- Operating Cash Flow Per Share(RMB): -0.6390
- Undistributed Profit Per Share(RMB): -0.8231
- Capital Reserve Per Share(RMB): 12.4332
2. Main Business
The main business covers:
- Independent R&D of core underlying technologies for molecular detection
3. Company Basic Information
- Company Name: Jiangsu Kangwei Century Biotechnology Co., Ltd.
- Listing Date: 2022-10-25
- Industry: Pharmaceutical Manufacturing
- Address: 4th Floor, TQB Building, No.1 Yaocheng Avenue, Taizhou City, Jiangsu Province
- Website: https://www.cwbio.com/
- Company Profile: The company was established in 2020 through the overall transformation of Jiangsu Kangwei Century Biotechnology Co., Ltd., focusing on the independent R&D of core underlying technologies for molecular detection. It was listed on the Shanghai Stock Exchange STAR Market on October 25, 2022.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Rongtong Health Industry Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 260.00 | 6.84 |
| 2 | Jiangsu Kangwei Century Biotechnology Co., Ltd. Special Securities Account for Repurchase | General Legal Person | 256.19 | 6.74 |
| 3 | CITIC Securities - China CITIC Bank - CITIC Securities Kangwei Century Employee Participation in STAR Market Strategic Placement Collective Asset Management Plan | General Legal Person | 105.19 | 2.77 |
| 4 | Yuanxinyongfeng Medicine and Health Hybrid Securities Investment Fund Class A | Fund | 95.00 | 2.50 |
| 5 | Honghui Holding Group Co., Ltd. | General Legal Person | 91.00 | 2.40 |
| 6 | Anhui Jingxi Private Fund Management Co., Ltd. - Jingxi Yangfan Qiming No.2 Private Securities Investment Fund | Private Securities Investment Fund | 82.00 | 2.16 |
| 7 | Shenzhen Hanjinliang Private Fund Management Co., Ltd. - Hanjinliang Allocation No.6 Private Securities Investment Fund | Private Securities Investment Fund | 80.27 | 2.11 |
| 8 | Jiangsu Yida Achievements Innovation and Entrepreneurship Investment Fund (Limited Partnership) | General Legal Person | 73.00 | 1.92 |
| 9 | Taizhou City Transformation and Upgrade Industrial Investment Fund (Limited Partnership) | General Legal Person | 73.00 | 1.92 |
| 10 | Rongtong Value Growth Hybrid Securities Investment Fund Class A | Fund | 45.00 | 1.18 |
5. Concept Sectors
- Gene Concept
- Helicobacter Pylori
- Margin Trading & Securities Lending
- Consecutive Losses
- Below IPO Price
- High Margin Financing
- Fund Reduction
- New Private Placement
- Micro/Small Cap Stock
Remarks
- Data update date: 2025-11-01
- Data source: Public Market Information